Pathological features of tissues and cell populations during cancer cachexia.
Daniela Di GirolamoShahragim TajbakhshPublished in: Cell regeneration (London, England) (2022)
Cancers remain among the most devastating diseases in the human population in spite of considerable advances in limiting their impact on lifespan and healthspan. The multifactorial nature of cancers, as well as the number of tissues and organs that are affected, have exposed a considerable diversity in mechanistic features that are reflected in the wide array of therapeutic strategies that have been adopted. Cachexia is manifested in a number of diseases ranging from cancers to diabetes and ageing. In the context of cancers, a majority of patients experience cachexia and succumb to death due to the indirect effects of tumorigenesis that drain the energy reserves of different organs. Considerable information is available on the pathophysiological features of cancer cachexia, however limited knowledge has been acquired on the resident stem cell populations, and their function in the context of these diseases. Here we review current knowledge on cancer cachexia and focus on how tissues and their resident stem and progenitor cell populations are individually affected.
Keyphrases
- papillary thyroid
- stem cells
- healthcare
- squamous cell
- gene expression
- childhood cancer
- type diabetes
- patient safety
- cardiovascular disease
- end stage renal disease
- newly diagnosed
- quality improvement
- endothelial cells
- single cell
- ejection fraction
- young adults
- high throughput
- cell therapy
- bone marrow
- genetic diversity
- metabolic syndrome
- patient reported outcomes
- mesenchymal stem cells
- glycemic control
- emergency medicine